<DOC>
	<DOCNO>NCT02484872</DOCNO>
	<brief_summary>Systemic inflammation potential prognostic factor cancer . Inflammation score Glasgow score test cancer specifically lung cancer patient . The aim study look prognostic predictive value inflammation cancer evolution , risk complication lead ICU admission risk death .</brief_summary>
	<brief_title>Has Inflammation Significant Implication Lung Cancer Evolution ?</brief_title>
	<detailed_description>Patients newly diagnose lung cancer eligible . All patient blood sample allow test inflammation cytokine analyse diagnosis , work-up case complication .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Lung neoplasm irrespective stage , histology Previously treat lung neoplasms A history prior malignant tumour , except nonmelanoma skin cancer situ carcinoma cervix cure malignant tumour ( 5 year diseasefree interval )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Glasgow score</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Emergency</keyword>
</DOC>